Arcus Biosciences
RCUS
RCUS
210 hedge funds and large institutions have $2.57B invested in Arcus Biosciences in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 81 increasing their positions, 57 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 208 → 210 (+2)
11% less capital invested
Capital invested by funds: $2.89B → $2.57B (-$321M)
17.48% less ownership
Funds ownership: 112.48% → 95% (-17%)
Holders
210
Holding in Top 10
5
Calls
$12.6M
Puts
$3.61M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$25.9M | |
| 3 | +$19.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$18.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$8.78M |
Top Sellers
| 1 | -$68M | |
| 2 | -$35.4M | |
| 3 | -$22.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$20.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$19.4M |
